UroGen Pharma Ltd. Quarterly Return On Assets in % from Q3 2018 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
UroGen Pharma Ltd. quarterly/annual Return On Assets history and growth rate from Q3 2018 to Q2 2024.
  • UroGen Pharma Ltd. Return On Assets for the quarter ending June 30, 2024 was -53.2 %, a 42.4% increase year-over-year.
  • UroGen Pharma Ltd. annual Return On Assets for 2023 was -70.5 %, a 7.56% increase from 2022.
  • UroGen Pharma Ltd. annual Return On Assets for 2022 was -76.3 %, a 13% increase from 2021.
  • UroGen Pharma Ltd. annual Return On Assets for 2021 was -87.7 %, a 0.64% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -53.2 +39.2 +42.4% Apr 1, 2024 Jun 30, 2024
Q1 2024 -62.5 +22.9 +26.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -70.5 +5.76 +7.56% Oct 1, 2023 Dec 31, 2023
Q3 2023 -78.2 -0.09 -0.12% Jul 1, 2023 Sep 30, 2023
Q2 2023 -92.3 -12 -14.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 -85.3 -6.36 -8.06% Jan 1, 2023 Mar 31, 2023
Q4 2022 -76.3 +11.4 +13% Oct 1, 2022 Dec 31, 2022
Q3 2022 -78.1 +10.8 +12.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -80.4 +6.57 +7.56% Apr 1, 2022 Jun 30, 2022
Q1 2022 -79 +10.7 +11.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -87.7 -0.56 -0.64% Oct 1, 2021 Dec 31, 2021
Q3 2021 -88.9 -7.21 -8.82% Jul 1, 2021 Sep 30, 2021
Q2 2021 -86.9 -18.1 -26.2% Apr 1, 2021 Jun 30, 2021
Q1 2021 -89.7 -31.4 -54% Jan 1, 2021 Mar 31, 2021
Q4 2020 -87.1 -41.4 -90.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -81.7 -37.9 -86.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 -68.9 -19 -38% Apr 1, 2020 Jun 30, 2020
Q1 2020 -58.2 -1.44 -2.54% Jan 1, 2020 Mar 31, 2020
Q4 2019 -45.7 +19.1 +29.4% Oct 1, 2019 Dec 31, 2019
Q3 2019 -43.8 +12.7 +22.5% Jul 1, 2019 Sep 30, 2019
Q2 2019 -49.9 Apr 1, 2019 Jun 30, 2019
Q1 2019 -56.8 Jan 1, 2019 Mar 31, 2019
Q4 2018 -64.8 Oct 1, 2018 Dec 31, 2018
Q3 2018 -56.5 Jul 1, 2018 Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.